Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Eschericia coli urinary tract infection

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 2, 2002, Pages 367-371

  Leflon Guibout, Véronique ^a   Ternat, Géraldine ^a   Heym, Beate ^a   Nicolas Chanoine, Marie Hélène ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG EXPOSURE; ESCHERICHIA COLI; FECES ANALYSIS; GRAM NEGATIVE BACTERIUM; HUMAN; IN VIVO STUDY; INFECTION RISK; INTESTINE; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK FACTOR; URINALYSIS; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-INFECTIVE AGENTS, URINARY; CONFIDENCE INTERVALS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; HUMANS; INFANT; MIDDLE AGED; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 0036174641     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli
2. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors
3. Inhibitor-resistant TEM β-lactamases: Phenotypic, genetic and biochemical characteristics
4. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production
5. TEM genes
6. Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients
7. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli
8. Augmentin: Laboratory studies
9. Statement 1996 Ca-SFM zone sizes and MIC breakpoints for non-fastidious organisms
10. Use of molecular analysis in pathophysiological investigation of late-onset neonatal Escherichia coli meningitis
11. Typing of Listeria monocytogenes strains by random amplification of polymorphic DNA
12. Typing of Clostridium perfringens strains by use of random amplified polymorphic DNA (RAPD) system in comparison with zymotyping
13. Discriminatory detection of inhibitor-resistant β-lactamases in Escherichia coli by single strand conformational polymorphism-PCR
14. Guidelines for management of adult community-acquired lower respiratory tract infections
15. Trends in antimicrobial drug use in the community-France, 1981-1992
16. Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in France
17. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)
18. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli